Sangamo Therapeutics
SGMO
#9893
Rank
$70.42 M
Marketcap
$0.17
Share price
-5.56%
Change (1 day)
-63.04%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of September 2025 : $6.24 Million USD

According to Sangamo Therapeutics 's latest financial reports the company has $6.24 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$22.77 M-72.53%
2023-12-31$$82.88 M-71.9%
2022-12-31$$0.29 B-21.42%
2021-12-31$$0.37 B-24.53%
2020-12-31$$0.49 B14.93%
2019-12-31$$0.43 B17.83%
2018-12-31$$0.36 B95.45%
2017-12-31$$0.18 B37.96%
2016-12-31$$0.13 B-29.23%
2015-12-31$$0.19 B-6.87%
2014-12-31$$0.20 B69.77%
2013-12-31$$0.12 B87.55%
2012-12-31$$64.89 M-19.01%
2011-12-31$$80.13 M43.33%
2010-12-31$$55.9 M-22.12%
2009-12-31$$71.78 M29.58%
2008-12-31$$55.39 M-23.19%
2007-12-31$$72.12 M48.08%
2006-12-31$$48.7 M28.8%
2005-12-31$$37.81 M16.79%
2004-12-31$$32.37 M-27.5%
2003-12-31$$44.66 M-17.67%
2002-12-31$$54.24 M-34.13%
2001-12-31$$82.34 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$81.18 B 1,300,332.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.19 B 147,104.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$18.65 B 298,661.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
$16.76 B 268,408.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$23.43 B 375,216.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$45.93 B 735,620.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$1.07 B 17,125.37%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$6.21 B 99,405.21%๐Ÿ‡บ๐Ÿ‡ธ USA